- A Phase 1/2a Study to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Vaccine Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Vaccine Regimens, with High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention (HIV-V-A004/IPCAVD 009)
Many clinical research studies need healthy volunteers to participate as research subjects. Healthy volunteers who choose to participate in a clinical trial may help advance medical knowledge, provide scientific information important to developing new treatments for disease and gain personal satisfaction from indirectly helping those who suffer from disease. Some studies compensate volunteers. In some studies volunteers will receive a thorough physical examination.